SCHEMBL597083

SCHEMBL597083

OC[C@H]1O[C@@H](n2cnc3c(O)nc(S)nc32)[C@H](O)[C@@H]1O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.63
TP53 P04637 1/20 0.63
NT5E P21589 1/20 0.61
HIF1A Q16665 1/20 0.61
ADORA2A P29274 4/20 0.60
ADORA2B P29275 3/20 0.60
CYP2C19 P33261 1/20 0.58
HPGD P15428 1/20 0.58
ADORA3 P0DMS8 3/20 0.58
ADORA1 P30542 2/20 0.58
DPP4 P27487 1/20 0.58
MEN1 O00255 1/20 0.58
SLC28A1 O00337 1/20 0.58
MAP3K7 O43318 1/20 0.58
SLC28A2 O43868 1/20 0.58
GAPDH P04406 1/20 0.58
MAPK1 P28482 1/20 0.58
STAT6 P42226 1/20 0.58
PI4KA P42356 1/20 0.58
KMT2A Q03164 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL597084 1.00 LMNA (0.63) LMNATP53NT5EHIF1AADORA2A
SCHEMBL11811220 0.99 LMNA (0.62) LMNATP53NT5EHIF1AADORA2A
SCHEMBL11805362 0.90 LMNA (0.66) LMNATP53NT5EHIF1AADORA2A
Xanthosine SCHEMBL8665102 0.89 LMNA (0.65) LMNATP53NT5EHIF1AADORA2A
Xanthosine SCHEMBL6676995 0.89 LMNA (0.65) LMNATP53NT5EHIF1AADORA2A
Xanthosine SCHEMBL11523732 0.89 LMNA (0.65) LMNATP53NT5EHIF1AADORA2A
Xanthosine SCHEMBL188120 0.89 LMNA (0.65) LMNATP53NT5EHIF1AADORA2A
Xanthosine SCHEMBL5352244 0.88 LMNA (0.63) LMNATP53NT5EHIF1AADORA2A
Guanosine SCHEMBL8661570 0.86 CYP2C19 (0.73) LMNANT5EHIF1AADORA2AADORA2B
SCHEMBL6295569 0.86 LMNA (0.77) LMNATP53NT5EHIF1AADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108392680-B Plastic full-degradable hard tissue filling biological material 珠海睿展生物材料有限公司 2020-12-18 CN claimed
CN-108392680-A Biomaterial is filled by a kind of shaping degradable sclerous tissues 苏州纳晶医药技术有限公司 2018-08-14 CN claimed
WO-2024073025-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME MARS, INCORPORATED (US) 2024-04-04 WO disclosed
CN-108392680-B Plastic full-degradable hard tissue filling biological material 珠海睿展生物材料有限公司 2020-12-18 CN disclosed
CN-108392680-A Biomaterial is filled by a kind of shaping degradable sclerous tissues 苏州纳晶医药技术有限公司 2018-08-14 CN disclosed
US-8440812-B2 Analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation NOGRA PHARMA LIMITED (IE) 2013-05-14 US disclosed
US-20120094948-A1 Analogous Compounds of 6-Thioguanosine Triphosphate, their use in Medical Fields and Processes for their Preparation GIULIANI INTERNATIONAL LIMITED 2012-04-19 US disclosed
US-8114986-B2 Analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation GIULIANI INTERNATIONAL LIMITED (IE) 2012-02-14 US disclosed
US-20100323980-A9 Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation NOGRA PHARMA LIMITED (IE) 2010-12-23 US disclosed
US-20090258837-A1 Analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation GIULIANI INTERNATIONAL LIMITED (IE) 2009-10-15 US disclosed
CN-101243102-A Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation GIULIANI INT LTD (IE) 2008-08-13 CN disclosed
EP-1907407-A1 IMPROVEMENTS TO ANALOGOUS COMPOUNDS OF 6-THIOGUANOSINE TRIPHOSPHATE, THEIR USE IN MEDICAL FIELDS AND PROCESSES FOR THEIR PREPARATION Giuliani International Limited (IE) 2008-04-09 EP disclosed
CN-1300304-C 5-amino-4-carbamyl imidazole nucleoside producing bacterium and preparation method thereof GUANGDONG PROV MICROBE INST (CN) 2007-02-14 CN disclosed
WO-2007010515-A1 IMPROVEMENTS TO ANALOGOUS COMPOUNDS OF 6-THIOGUANOSINE TRIPHOSPHATE, THEIR USE IN MEDICAL FIELDS AND PROCESSES FOR THEIR PREPARATION GIULIANI INTERNATIONAL LIMITED (IE) 2007-01-25 WO disclosed
CN-1710065-A 5-amino-4-carbamyl imidazole nucleoside producing bacterium and preparation method thereof GUANGDONG PROV MICROBE INST (CN) 2005-12-21 CN disclosed
US-5213972-A Production of thymidine and deoxyuridine, intermediates for AZT CHEMGEN CORPORATION (US) 1993-05-25 US disclosed
EP-0219838-A2 Carbocyclic purine nucleosides, their production and use Takeda Chemical Industries, Ltd. (JP) 1987-04-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258837-A1 Analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation TPMT, MTAP, G6PD LMNA 4630/4885TP53 2809/4885NT5E 209/4885
US-20120094948-A1 Analogous Compounds of 6-Thioguanosine Triphosphate, their use in Medical Fields and Processes for their Preparation TPMT, MTAP, G6PD LMNA 4630/4885TP53 2809/4885NT5E 209/4885
US-20100323980-A9 Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation TPMT, G6PD, MTAP LMNA 4616/4885TP53 3205/4885NT5E 257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.